SISu specifications

Information


Unique identifier OMICS_16573
Name SISu
Alternative name Sequencing Initiative Suomi
Restrictions to use None
Community driven Yes
Data access File download, Browse
User data submission Not allowed
Version 4.1
Maintained Yes

Documentation


Maintainer


  • person_outline Hannele Laivuori <>

Publication for Sequencing Initiative Suomi

SISu institution(s)
Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA; Department of Genetics, Harvard Medical School, Boston, MA, USA; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
SISu funding source(s)
This work was supported by the following grants: the European Commission FP7 projects no. 201413 ENGAGE, project no. 242167 SynSys, Health-2010 -projects no. 261433 BioSHare and project no. 261123 gEUVADIS, the Academy of Finland grants no. 251704 and 263401, the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, NIH/RFA-HL-12-007, the European Commission Health-2010-project no. 261433 BioSHare, the Academy of Finland grants no 255847 and no 251217, the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, the Academy of Finland grant #139635, the Finnish Foundation for Cardiovascular Research, the Australian National Health and Medical Research Council Early Career Fellowship no. 637400, the Wellcome Trust Research Career Development Fellow 086596/Z/08/Z, GoT2D RC2-DK088389, GoT2D Wellcome Trust 090367, Wellcome Trust 098381, T2DGENES NIDDM U01-DK-085545, DK062370, DK085584, DK088389, Academy of Finland grants 141054, 265240, 263278, Academy of Finland grant 250422, the European Union's Seventh Framework Programme FP7/2007-2013 (HEALTH-F2-2011-278913, BiomarCaRE), the Targeted Financing from the Estonian Ministry of Science and Education SF0180142s08, the US National Institute of Health R01DK075787, the Development Fund of the University of Tartu grant SP1GVARENG, the European Regional Development Fund to the Centre of Excellence in Genomics (EXCEGEN) grant 3.2.0304.11-0312, and FP7 grant 313010.

SISu reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review SISu